Guardian Pharmacy Services, Inc.
Financials
Valuation Metrics
Guardian Pharmacy Services, Inc.'s Market Cap is $2.85B. At end of 2025 it was $1.91B. Ranked #1778 of 3,121 in US market (top 57%), #1139 of 1,658 on NYSE (top 69%), #106 of 205 in Health Care Equipment & Services (top 52%) by Market Cap.
Investment Metrics(as of 2026-09-18)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $2.85B | US#1,778/3,121 Sec#106/205 |
| Revenue | $1.46B | US#1,652/3,121 Sec#101/205 |
| Net Income | $66M | US#1,777/3,121 Sec#89/205 |
| Total Assets | $444M | US#2,818/3,121 Sec#165/205 |
| Net Assets | $246M | US#2,611/3,121 Sec#153/205 |
| Employees | 3,600 | US#1,399/3,121 Sec#98/205 |
| Value | ||
| P/E | 43.18x | US#1,851/3,121 Sec#91/205 |
| P/B | 11.59x | US#2,673/3,121 Sec#171/205 |
| P/S | 1.94x | US#1,271/3,121 Sec#86/205 |
| EV/EBITDA | 24.49x | US#2,095/3,121 Sec#104/205 |
| FCF Yield | 2.80% | US#1,888/3,121 Sec#110/205 |
| Profitability | ||
| ROE | 26.83% | US#359/3,121 Sec#17/205 |
| ROA | 14.86% | US#233/3,121 Sec#13/205 |
| Op. Margin | 6.27% | US#1,881/3,121 Sec#99/205 |
| Revenue Growth | 10.31% | US#1,242/3,121 Sec#84/205 |
| Financial Health | ||
| Debt Ratio | 75.70% | US#840/3,121 Sec#87/205 |
| Total Debt | $35M | US#2,674/3,121 Sec#159/205 |
| FCF | $80M | US#1,829/3,121 Sec#106/205 |
| Cash | $90M | US#2,288/3,121 Sec#144/205 |
| Current Ratio | 1.65x | US#1,509/3,121 Sec#133/205 |
| Net Debt/EBITDA | -0.48x | US#393/3,121 Sec#30/205 |
| Performance | ||
| 1Y Return | 70.12% | US#386/3,121 Sec#40/205 |
| 1M Return | 18.37% | US#110/3,121 Sec#18/205 |
| From 52W High | -7.00% | US#444/3,121 Sec#48/205 |
| 1Y MDD | -15.45% | US#364/3,121 Sec#7/205 |
| Trading | ||
| Volume | 582,856 shares | US#1,963/3,121 Sec#138/205 |
| Trading Value | $26M | US#1,752/3,121 Sec#122/205 |
| Per Share | ||
| EPS | $1.04 | US#1,665/3,121 Sec#87/205 |
| BPS | $3.88 | US#2,378/3,121 Sec#150/205 |
Company Info
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.